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Abstract: Chronic obstructive pulmonary disease (COPD) is a progressive disease of the lungs
characterised by chronic inflammation, obstruction of airways, and destruction of the parenchyma
(emphysema). These changes gradually impair lung function and prevent normal breathing. In 2002,
COPD was the fifth leading cause of death, and is estimated by the World Health Organisation (WHO)
to become the third by 2020. Cigarette smokers are thought to be the most at risk of developing
COPD. However, recent studies have shown that people with life-long exposure to biomass smoke
are also at high risk of developing COPD. Most common in developing countries, biomass fuels such
as wood and coal are used for cooking and heating indoors on a daily basis. Women and children
have the highest amounts of exposures and are therefore more likely to develop the disease. Despite
epidemiological studies providing evidence of the causative relationship between biomass smoke
and COPD, there are still limited mechanistic studies on how biomass smoke causes, and contributes
to the progression of COPD. This review will focus upon why biomass fuels are used, and their
relationship to COPD. It will also suggest methodological approaches to model biomass exposure
in vitro and in vivo.
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1. Overview
Chronic obstructive pulmonary disease (COPD) can be thought of as the physical manifestation of
the pulmonary response to chronic inhalation of noxious particles. The prevailing theory is that these
noxious particles induce an inflammatory response and tissue damage, and in susceptible individuals,
these result in COPD. Susceptibility to COPD may depend upon epigenetic reprogramming of lung
cells [1], inheritable genetic susceptibility [2], and intrinsic differences in lung structure [3], with the
relative contribution of each being unknown. Airway inflammation is a key immediate immunological
response after exposure, which is a key marker for the pathological effects of this disease. This involves
the recruitment of inflammatory cells such as neutrophils, macrophages, eosinophils and T cells
into the airways, which all contribute to tissue damage and airway remodeling. In comparison to
healthy people, COPD patients have an exaggerated inflammatory response; for the same amount
of stimulus, there are more inflammatory cells and higher pro-inflammatory cytokine levels in
the lungs [4]. Clinically the severity of COPD is classified by the amount of airflow obstruction.
Pathologically COPD is characterised by three interrelated processes: remodeling of the small airway
walls, loss of small airways, and emphysema—the destruction of alveolar structure leading to airspace
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enlargement and loss of elastic recoil and ultimately of peribronchiolar attachments. Hogg et al.
carried out a comprehensive pathological assessment of small airway thickening in COPD in which
they inflammatory cell increased according to the severity of COPD [5]. Inflammatory cells release
high levels of reactive oxygen species (ROS) in COPD, which is also found in biomass smoke, and
induce oxidative stress (see Figure 1). This process can then activate proteases such as matrix
metalloproteinases and neutrophil elastase, and increase inflammatory cell influx at the same time [6,7].
In turn, these cells will further release more proteolytic enzymes, which can be activated and cause
break down of connective tissues in the lung [8,9]. Therefore, airway inflammation, oxidative stress
and protease/antiprotease imbalance are interlinked and all contribute to the development of COPD.
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Lung pathology involves the destruction of the parenchyma (i.e., emphysema), mucus
hypersecretion and thickening, fibrosis, occlusion and loss of t e small airways. The relative extent of
each of these varies from person to person. The e patholo ical changes are manifest d as symptoms
associated with airflow limitation such as coughing, wheezing, and shortness of breath [10]. Disease
heterogeneity [11–13], both in terms of lung pathology, the immunological response, and symptoms
leads to simplification in clinical trial design and in vitro and in vivo experimentation. For example,
because of the strong association with the risk of COPD, most investigators have focused upon cigarette
smoke exposure to understand the pathophysiology of COPD. Biomass smoke exposure has been
posited as the greatest risk factor for the development of COPD globally [14], but despite this, there
have been remarkably few mechanistic studies on how biomass smoke causes, and contributes to the
progression of COPD.
2. Prevalence of Biomass Smoke Exposure
Biomass smoke is one of the major air pollutant and con ributors of househo d air pollution
worldwide. It is considered one of the leading environmental risk factors of several diseases, including
COPD and acute lower respiratory disease, and is thought to cause 4 million deaths annually across the
globe [15,16]. Biomass smoke is the result of the combustion of different types of fuels such as wood,
animal dung, and crop residues undertaken to create the energy necessary for cooking and heating in
many households worldwide [17]. Recent estimates are that 3 billion people rely on biomass fuels for
domestic purposes [18]. The proportion of households using biomass fuels varies substantially across
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the globe (and even in the same continent) due to biomass availability and relative costs compared
with other energy sources such as electricity and liquid petroleum gas. This makes quoting percentages
per region less informative although there is a clear trend for greater use in the undeveloped and
developing world [19].
There are many reasons why biomass fuels are used. In developing countries where poverty
is prevalent, burning biomass fuels is a cheaper alternative compared to liquefied petroleum gas
or electricity. Also, biomass fuels are also more accessible, especially for people living in rural
places [20,21]. Current predictions are that domestic consumption of biomass fuels will remain
substantial for decades to come, particularly in rural areas [20,21]. The most common type of biomass
used worldwide is wood; however, most people in developing countries still use a combination of
different solid fuel sources depending on availability [17,22]. In developing countries women and
children have the highest biomass smoke exposure due to cultural practices such as indoor cooking in
housing with very poor air ventilation. The absence of chimneys or pipes prevents the smoke venting
outside and therefore, particles become trapped and diffuse into the surroundings [23,24]. During the
burning of these fuels, people indoors can be exposed with up to 30,000 µg/m3 of particulate matter
(PM) sized 10 µm or smaller (i.e., PM10 which includes PM2.5 µm or smaller (PM2.5), while an
average concentration throughout the day is approximately 300–5000 µg/m3 [25]. We have previously
evaluated PM production from biomass and tobacco cigarettes and under laboratory conditions have
found that the profile of PM production is very similar [26]. The concentration of PM from second-hand
smoking can be up to 704 ug/m3 [27].
However, one stark difference to exposure to second-hand tobacco smoke is that as a result of
remaining indoors, woman and children are exposed for about 3 to 7 h a day to biomass smoke [28].
The WHO guideline [29] for PM10 concentration exposure is only 50 µg/m3 for a 24 h period, which is
extremely low compared to observed concentrations indoors where biomass fuels are burnt. The Global
Burden of Disease 2010 study found that household air pollution is the second highest risk factor of ill
health for women and girls globally [30].
Exposure to biomass smoke is not exclusively an issue in the developing world. Indoor and
outdoor air pollution in developed countries was previously estimated to contribute to 23% of the
total global exposure to particulate matter pollution [21]. Use of indoor wood fires, seen as a cheaper,
renewable (and possibly more “natural”) alternative to electrical and gas heating; is increasing in
developed countries thus increasing biomass smoke exposure [31]. In 2011, in Australia, 5% of
households surveyed used wood stoves for indoor heating. The use of wood fire as a source of heating
between different states did not vary dramatically with the exception of Tasmania where wood fire
heating was used in 20% of households [32]. Domestic use of wood fires in developed countries shares
some features with that of developing countries including that its use is more common amongst the
rural poor.
Interestingly, biomass fuel use in developed countries has been shown to increase during times of
recession [33]. However, in the developed countries, use of biomass fuel is more seasonal since the
principal function is indoor heating; there is better venting of the resultant smoke and duration of
exposure to children is usually less because during the day they are attending schools [34]. With regard
to cooking, in developed countries, biomass fuels are may be chosen for the flavor that they impart
during cooking processes (e.g., barbecues, smoked meats, wood-fired pizza). Outside the home, some
occupations such as firefighters involve high exposure rates to biomass smoke [35]. While in countries
with substantial park and bushlands, such as Australia, Canada and the USA, an additional, seasonal
source of biomass smoke are bushfires. Across the globe intentional use of fire as part of agricultural
practices is another seasonal outdoor contributor to biomass smoke [31].
3. Biomass Smoke as a Toxic Air Pollutant
Biomass smoke has been shown to consist of over 200 different compounds, which includes
a significant number of toxic compounds. Some of these include carbon monoxide (CO), varying
Toxics 2017, 5, 36 4 of 16
sizes of particulate matter (PM), mostly PM10; sulphur and nitrogen oxides, polycyclic aromatic
hydrocarbons (PAH), aldehydes, free radicals and non-radical oxidising species; and volatile organic
compounds [20,23,31]. Many of these compounds cause respiratory diseases while some are
carcinogenic (reviewed in [36]). The exact chemical composition of biomass smoke is dependent
upon the fuel type, the temperature of burning, whether an open fire or incinerator is used, and
local conditions (e.g., wind speed, humidity, indoor or outdoor fires). It is the author’s opinion that
whilst studying the toxicological and health effects of individual components of biomass smoke is
informative, people are exposed to a toxic mixture of all components and it is difficult to extrapolate
individual effects to such complex mixtures. As an example, Table 1 gives the top 25 chemical groups
in terms of g/kg of wood smoke. In comparison, tobacco smoke constituents have been intensively
studied, and whist much more is known about the contents of the smoke, it is not known which of the
70 carcinogens is more likely to cause lung cancer in any given individual.
In epidemiological studies if source sampling is not available it is possible to estimate biomass
exposure levels using tracer chemicals such as levoglucosan. Levoglucosan is a cellulose pyrolysis
product, and has been used as a general organic tracer for wood smoke particles [37,38]. Such tracer
chemicals allow exposures and risk of diseases to be calculated even when people are living several
kilometers away from the sauce of the biomass smoke.
Table 1. The most abundant constituents of wood smoke adapted from [39].
Pollutant Physical State Emissions for g/kg Wood
Carbon Monoxide vapour 80–370
Methane vapour 14–25
VOCs (C2–C7) vapour 7–27




Alkyl Benzenes (including toluene) vapour 1–6
Aldehydes (including Formaldehyde, Acrolein, Propionaldehyde,
Butryaldehyde, Acetaldehyde, Furfural) 0.6–5.4
Acetic Acid vapour 1.8–2.4
Formic Acid vapour 0.06–0.08
Nitrogen Oxides (NO,NO2) vapour 0.2–0.9
Sulfur Dioxide vapour 0.16–0.24
Methyl chloride vapour 0.01–0.04
Napthalene vapour 0.24–1.6
Substituted Napthalenes vapour/particulate 0.3–2.1
Total Particle Mass particulate 7–30
particulate
Particulate Organic Carbon particulate 2–20
particulate
Oxygenated PAHs vapour/particulate 0.15–1
Oxygenated Monoaromatics (including Guaiacol (and derivatives), Phenol
(and derivatives), Syringol (and derivatives), and Catechol (and derivatives) 1–7
PAHs (including Fluorene, Benzo(e)pyrene), Chrysene vapour particulate <1 g
4. Biomass Smoke-Induced COPD
Biomass smoke exposure is a prominent risk factor for developing several airway diseases.
For example relative to non-exposed people, those exposure to biomass smoke have an odds ratio
of 2.44 (95% CI, 1.9–3.33) for developing COPD [40]. While among women over 30 who were
predominantly undertaking domestic duties in rural areas the relative risk for COPD was estimated
as either 3.2 (95% CI 2.3–4.8) [41] or 2.14 (95% CI 1.78–2.58) [42]. In children under five years
from developing countries, the relative risk for acute lower respiratory disease was estimated at
2.3 (95% CI 1.9–2.7 [41]) or 1.78 (95% CI 1.45–2.18) [43]. While for lung cancer in women over 30
exposed to coal smoke the relative risk was 1.9 (95% CI 1.1–3.5) [41]. There is also evidence for adverse
impacts in terms of low birth weight, cardiovascular disease and early mortality [17,22,31,44].
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Pathologically biomass induced COPD is distinct from cigarette smoke induced COPD.
Rivera et al. were the first to carry out an elegant study into the pathology of biomass induced
COPD [45]. In comparison to cigarette smoke-exposed women with COPD, the lungs of biomass
smoke exposed women with COPD had more pigment deposition and fibrosis (collectively referred to
as bronchial anthracofibrosis), and thicker pulmonary arterial intima, but had reduced emphysema.
Bronchial anthracofibrosis is not unique to biomass smoke induced COPD [46], and for example occurs
in around 50% of people with tuberculosis [47]
5. Life-Long Exposure to Biomass Smoke in COPD Patients
Adults with COPD linked to biomass exposure in developing countries would typically have
a life-long exposure to biomass smoke, from when they were children until death, and even after a
COPD diagnosis, especially in older women having a higher risk because of their increased cumulative
exposure. Thus, the typical person suffering from COPD linked to biomass exposure is an elderly
woman who most likely grew up in a rural area in an underdeveloped or developing country. Despite
this, there are still limited studies on patients with COPD within these areas where biomass PM
concentrations are abnormally high compared to most developed countries. In terms of public health
measures, intervention studies such as the implementation of low-cost, improved wood-burning stoves
(which reduce personal exposures of PM and CO levels), and provision of liquefied petroleum gas
stoves, have been carried out. Compared to open fires, the use of efficient wood stoves was shown to
reduce up to 71% of particulate matter of sizes of 2.5 µm or smaller (PM2.5) concentrations near the
stove area [48]. Another study showed significantly lower risk of respiratory symptoms and reduced
decline in forced expiratory volume (FEV1) after a year of using efficient wood stoves called “Patsari
stoves” in Mexico [49]. Due to the persistent exposure of biomass smoke despite developing COPD in
patients, it is important to investigate its effects on the disease progression.
6. How Does Biomass Smoke Exposure Contribute to the Development of COPD?
Regarding COPD, the global impact of biomass smoke exposure strongly supports further research
into the mechanisms by which this significant household pollutant could induce COPD in susceptible
individuals. Researchers have utilised cellular-, animal- and human exposure models to investigate
these mechanisms.
6.1. In Vitro Studies
Studies that rely upon the exposure of either whole biomass smoke (or individual and/or
combinations of toxic components) to cells in vitro allow for a more precise elucidation of the
pathological mechanisms involved. Where such in vitro models of biomass smoke exposure are
evaluated to sufficiently reflect central features of the disease in question, then such models provide the
first stage to evaluate both the efficacy of potential therapeutic agents and identify genetic components
of disease susceptibility. Comparisons of the responses elicited between cells isolated from healthy
donors and those with either disease (or increased risk of the disease) provide an ethically acceptable
alternative to in vivo exposure studies. However, there are several issues, which limit the impact of
such in vitro studies. One is a technical issue with regard to the delivery of the smoke. It is standard
practice with in vitro studies for the cells to be fully submerged in liquid growth media often containing
serum. Infusing culture medium with biomass smoke will potentially lead to the consumption of
active components of biomass smoke and the generation of potentially more toxic products from
reactions between biomass smoke components and components of the culture medium. This will be of
particular concern for studies looking at the responses of alveolar and airway epithelial cells. A second
caveat in the case of studies of the COPD being that the disease is the end result of chronic exposure
to noxious agents. Both the nature of the biomass smoke and the inclusion of a known noxious gas
(i.e., cigarette smoke) need to be considered as well as the duration of stimulation. Of interest is the
recent study from Happo et al. where they found that in vitro responses of a macrophage cell line to
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PM exposure (from wood combustion) varied with the time of exposure from 2 to 32 h [50]; whereas
humans can be exposed to biomass PMs delivery continuously in an indoor environment, which also
accumulate in the airway.
While keeping the limitations in mind, it remains that there have been significant findings made
regarding the impact of biomass smoke using in vitro systems. Biomass smoke exposure has been
shown to be pro-inflammatory. This response is observed with both smoke from the combustion
of wood [40,41] and animal dung [42]. Since there are many common components in these smokes,
it may suggest that a common component(s) of the smoke initiates inflammation [51,52]. This notion
is supported by a study where consistent inflammatory responses were found to 6 different types
of dung [43]. Biomass smoke-induced COPD may not simply be a by-product of biomass-smoke
induced inflammation as in vitro exposure of epithelial cells to biomass PM from wood epigenetically
modified the transcriptome resulting in altered gene expression [45]. It is also important to consider
the impact of biomass-smoke within the milieu of pro-inflammatory constituents that constitute
household pollutants [33]. In addition, components from biomass smoke may work synergistically with
other pro-inflammatory agents as recently Capistrano et al. have demonstrated that biomass smoke
exposure of human pulmonary fibroblasts in vitro resulted increased production of extracellular matrix
proteins that, in synergy with exposure to rhinovirus, resulted in a more inflammatory phenotype [44].
These findings are of signficance given the airway remodelling that is a common feature of COPD [53].
6.2. Animal Studies
Animal models of biomass exposure are particularly usefully to examine the response to biomass
smoke in systems that are more complex. Particularly the interplay of immune and respiratory systems
given previous in vitro studies demonstrating the modulation of leukocyte function in response to
biomass smoke exposure [50,54,55] and the role of leukocytes in the pathogenesis of inflammatory
diseases like COPD. They also allow for assessing more chronic exposure; while selective breeding
and the availability of gene knockout strains allow the development of models of inheritable risks.
Models have varied regarding the species used (for example rabbits [56], mice [57–59], rats [60–62],
guinea pigs [63,64] as well as larger species such as dogs and sheep [65,66]), the nature of the exposure
system (smoke from biomass, exposure to PM), and the length of the exposure (acute or chronic).
In reporting on the findings of The Toxicology and Animal Study Design Workgroup at the 2009
International Biomass Smoke Health Effects (IBSHE) conference, Migliaccio and Mauderly stated that
after reviewing many studies, it was only studies modeling COPD, emphysema, and the potential
CNS effects that the working group were not confident about with regard to providing reliable data
demonstrating the adverse effects of biomass smoke exposure [67]. However, from the perspective of
pulmonary disease researchers it is clear that while outcome measurements from numerous animal
studies have varied, such studies remain valid as they generally explore inflammatory mechanisms,
and/or the development of emphysema that manifest in human COPD. Many researchers now carry
out relatively complex models, which mimic multiple chronic exposures. For example, Sussan et al.
compared acute and chronic exposure to wood or cow dung PM in a murine model [25]. Acute exposure
resulted in the production of pro-inflammatory cytokines, neutrophilic inflammation, and increased
airway resistance and hyper-responsiveness, with PM from cow dung inducing greater responses than
wood smoke PM. In the same study, subchronic exposures increased eosinophilic inflammation and
destruction of alveoli tissue with wood smoke PM having greater activity.
6.3. Controlled Human Exposure
There have been many studies demonstrating a strong association between chronic exposure
to biomass smoke and poor health outcomes [16,17,23,29]. However, it must be acknowledged that
biomass smoke constitutes one of a number common and harmful household pollutants [51]. In vitro
and animal studies directly assessing the impact of exposure to biomass smoke alone have already
been discussed. However, there can be little doubt that human exposure models represent the most
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relevant and desirable model available to demonstrate a strong causal link between biomass smoke
exposure and disease. For ethical reasons these can only be limited to relatively short term exposures
and as such can only be used to examine acute effects of exposure. This, and current the lack of
a standardized model, limit their usefulness. In addition, human exposure studies do not always
yield consistent findings. Several recent studies examining any pro-inflammatory effects of biomass
smoke exposure of otherwise healthy volunteers illustrate this. Two three-hour chamber exposures to
incomplete combustion wood smoke (314 µg/m3) reduced inflammatory cells and mediators levels
in broncho-alveolar lavage, whilst T-cells and mast cells were increased in the airway walls from
endobronchial mucosal biopsies [68]; whereas Ghio and colleagues reported peripheral and lung
neutrophilia in response to four fifteen-minute exposures to wood smoke (485 ± 84 µg/m) over
a two-h period [69]. Disparate findings have also been observed when researchers assessed the
effect of biomass smoke on peripheral inflammation, Burchiel et al. exposed people to hardwood
smoke for 2 h (500 ug/m3), and then examined the response of peripheral blood mononuclear cells
ex vivo [70]. They found that T cell proliferation and cytokine production in response to hardwood
smoke exposure was highly variable from one individual to another, while the two responses in any
individual were consistent. While after exposure to wood smoke (0.41 mg/m3) in a reconstructed
Viking house for a one week stay [71], no adverse effects were demonstrable in participants with
regard to measures of genotoxicity nor with inflammatory markers (serum C-reactive protein, IL6,
IL8, TNF) nor with indicators of cardiovascular disease (cholesterol, triglycerides, and high-density
lipoproteins levels). The number of circulating monocytes expressing CD31 were slightly increased,
but not for the monocytes expressing CD11b, CD49d, and CD62L.
It is probably unreasonable to expect consistency between the studies of acute human exposure
given that relative amounts of active components will vary between sources and the inherent variability
between individuals with regard to pulmonary and immune responses to noxious stimuli as a reflection
of differences in general health status and life history of toxicant exposure.
7. Is Oxidative Damage the Major Mechanism of Biomass Smoke Induced COPD?
Oxidative stress can be conceived of as an imbalance between the burden of oxidizing species and
the antioxidant defenses of cells and tissues. The imbalance being such that the cell and tissue defenses
cannot deal with an increased burden of oxidants leaving an excess, which can target cell and tissue
components leading to alterations or loss of their functions [72,73]. With biomass smoke exposure, this
burden of oxidising species would be potentially derived from both components of the smoke [74]
as well as the inflammatory cells recruited to the lungs [75]. However, caution must be taken when
making any conclusions about the role of oxidative stress in the pathogenesis and/or pathology of any
disease. For example, demonstration of increased oxidant production commonly relies upon reactions
with indicator species such as dihydro-dichloro-fluorescein and dihydro-ethidium. The concern here
is that in a competent cell host antioxidant defenses may successfully consume the same reactive
oxidants in the absence of the competing reactions with the added indicator. Alternatively, researchers
have shown either decreased levels of low molecular weight antioxidants or an increase in the levels
of antioxidant enzymes in response to toxicant exposure.
The changes do represent the result of (or response to) an increased ROS load but not necessarily
an inadequate antioxidant response. The oxidative stress would only be supported by oxidative
damage to host cell and tissue components given that there are a number of well-characterised and
stable markers of such damage that researchers can measure. Ideally, studies would be designed to
find a significant correlation between physiological parameters and either a depletion in antioxidant
defence or markers of oxidative damage. However, association is not causation and such studies
need to be supported by follow up work where interventions that specifically boost host antioxidant
defence are matched with an amelioration or blunting of the effects of the toxicant on the functions
assessed [65].
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There have been several studies, which have assessed the association between oxidative stress and
acute or chronic biomass exposure. Several studies have examined rural Indian women chronically
exposed to biomass smoke. Dutta et al. demonstrated increased ROS production (as determined
by increased oxidation of added dihydro-dichloro-fluorescein) but decreased superoxide dismutase
(SOD) activity in epithelial and leukocytes isolated from sputum collected from such women [66].
The superoxide radical spontaneously dismutates to ROS hydrogen peroxide, while SOD catalyses
the same reaction. Superoxide is a transition metal reductant which promotes the formation of
Fenton-type ROS. Banerjee et al. [76] and Mukherjee and colleagues [77] found similar findings to
those of Dutta et al. [78]. Further to this, Dutta et al. [79] compared leukocyte ROS production and
erythrocyte SOD activity between Indian women who used liquid petroleum gas for cooking with
those who cooked using biomass fuel. With regard to cells from women who were exposed to biomass
smoke, ROS generation and SOD activity were, respectively, increased and decreased. Notably ROS
generation was positively correlated, and SOD activity was inversely correlated with PM10 and PM2.5
levels in the women’s blood. Additionally, Mukherjee and colleagues also demonstrated evidence
suggestive of oxidative attack upon DNA in the cells isolated from the sputum of rural Indian women
exposed to biomass smoke [77]. The assay for oxidative attack upon DNA relies on an assay of DNA
strand breakages. Also when comparing a group with biomass smoke-attributed COPD to matched
healthy subjects, Ceylan et al. found a significant higher level of DNA strand in isolated leukocytes as
well as increased serum levels of malondialdehyde and protein carbonyls (used as markers of lipid
and protein oxidation, respectively) [70].
In contrast to these studies, in a group of Danish female and male university students exposed to
biomass smoke in a reconstructed Viking-Age house for weekly periods Jensen et al. [80] found no
significant evidence of increased DNA strand breakage in peripheral blood leukocytes. These latter
results are not surprising noting that in healthy young men and women, short term exposure to
wood smoke increased the level of the antioxidant glutathione in broncho-alveloar lavage fluid [81]
highlighting the capacity of body to handle an increased oxidative burden through increasing its
antioxidant defence. The contrast with the earlier cited studies [70,76] is that chronic exposure to
biomass smoke may represent a persistent burden of ROS while antioxidant defence begins to fail
resulting in cell and tissue damage.
Two recent students have examined associations between the measures of oxidative stress and
lung function. Montano et al. [82] compared people with COPD attributed to biomass smoke exposure
with healthy matched controls. In the biomass smoke-COPD group, all measures of lung function
(FEV1, FVC and FEV1:FVC were significantly lower and there was a significant inverse correlation
with regard to serum SOD activity [82]. However, this was not the case for other antioxidant enzymes
(glutathione peroxidase, glutathione-S-transferase and glutathione reductase). In the same study,
an inverse relationship was also found for serum malondialdehyde levels and lung function. The same
inverse relationship between serum malondialdehyde levels (and serum SOD activity) and lung
function were found in mothers and children exposed to biomass smoke [83].
Malondialdehyde is commonly used as a measure of oxidative stress specifically, as mentioned
earlier, a measure of lipid peroxidation. However, there are several pathways by which
malondialdehyde can be formed and there are available more specific, validated and stable markers of
lipid peroxidation notably, F2-isoprostanes [84]. When F2-isoprostanes have been used as a marker of
oxidative stress, there have been conflicting results. Increased urine excretion of 8-iso-prostaglandin2α
was demonstrated in nine healthy volunteers exposed to two 4-h periods of wood smoke with 1
week apart [85]. However, these findings contrast to the study of Commodore et al. in which the
urinary levels of 8-iso-prostaglandin2α and 8-hydroxy-2′-deoxyguanosine (a stable and direct marker
of DNA oxidative damage) of Peruvian women who used wood fire stoves for cooking were assayed.
While these researchers were able to demonstrate a weak positive correlation between cooking time
and urinary 8-hydroxy-2′-deoxyguanosine levels, they found no significant differences in the urinary
levels of these markers between a control group and an intervention group who used a modified
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stove designed to reduce biomass smoke exposure. Nor were these researchers able to demonstrate
any significant positive correlation between the urine levels of these markers and measures of PM
exposure [86].
It should be apparent that studies purported to examine oxidative stress in cases of biomass
exposure need to be examined closely as to (i) the choice of assay; (ii) the characteristics of the biomass
exposure; and (iii) the cells and tissues, which are being examined. A broader question is what would
be the outcomes, in terms of better human health, if oxidative damage was identified as central to the
adverse effects of biomass smoke? What would be the advantages of interventions involving boosting
anti-oxidant defence over those working to reduce chronic domestic exposure to excessive amounts of
biomass smoke?
8. Other Potential Mechanisms
McCarthy et al., found that in pneumocytes wood smoke activates the aryl hydrocarbon
receptor [87]. They did not inhibit hydrocarbon receptor signaling so it is not possible to ascertain the
extent of the involvement of signaling via this receptor in response to biomass smoke. Sussan et al.
investigated signaling pathways of PM derived from wood and cow dung. They found that
inflammation is primarily driven via Toll-Like Receptors (TLR) 4 and 2, and IL-1R, using a series of
receptor knockout mice [25]. Since TLR 4 and 2 are both receptors for bacterial endotoxins, it is logical
that biomass derived PM would activate these receptors. We interpret the signaling via IL-1R as a
secondary signaling pathway since endotoxin activation of TLRs induces the production of IL-1 [88].
There are likely to be important differences between PM derived from biomass smoke (as used by
Sussan et al.) and biomass smoke itself (as used by McCarthy et al.), which also contains gaseous
components so it could in-fact be that these seemingly disparate findings are both correct, and different
components activate different receptors and pathways.
9. Biomass as a Risk Factor for COPD Exacerbations
Indoor pollutant exposures, including PM2.5 and NO2 have been associated with increased
respiratory symptoms and risk of COPD exacerbations [89]. In addition, outdoor PM concentrations
have been associated with an increase in COPD hospitalizations and mortality [90,91]. Outdoor
nitrogen dioxide (NO2) exposure has also been linked to increased COPD morbidity, including higher
rates of exacerbations [92,93]. In countries with low levels of biomass pollution, forest fires provide
an opportunity to explore the effects of biomass on COPD exacerbations. Several studies have
investigated the effects of forest fires on emergency department visits for COPD in New South Wales,
Australia. Perhaps unsurprisingly these epidemiological studies all showed an increase in COPD
exacerbations [94–96]. Using similar methodology, a smoke event was defined by an increase in the
average citywide PM10 or PM2.5 to exceed the 99th percentile of the entire study period. Admissions
for COPD were (OR 1.12, 95% CI 1.02, 1.24) [94] and (OR = 1.13, 95% CI = 1.05–1.22) [95]. A different
analysis method was used by Morgan et al. which revealed that 10 microg/m increase in bushfire
PM10 was associated with a 3.80% (1.40 to 6.26%) increase in COPD Admissions [96]. It is important
to recognise that further studies are needed to fully understand how exposure to biomass smoke may
precipitate COPD exacerbations globally, especially in situations which were constant with where
exposure occurs.
10. How Should In Vitro and In Vivo Models of Biomass Smoke Induced COPD Be Carried Out?
Clear evidence of a causative link between exposure to biomass smoke and respiratory events
and diseases is important as an impetus for programs that would directed to modifying the use of
biomass fuels. Population studies can at best show strong associations between biomass exposure and
adverse health outcomes but they cannot demonstrate causation. In vitro and in vivo studies allow the
examination of the direct action of biomass smoke upon cell, tissue and organ function. However, this
is not without its challenges, some of which have been already discussed. One of the greatest challenges
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to researchers investigating the effects of biomass smoke exposure using in vitro and in vivo models
is the inherent variability of biomass fuels. In contrast, cigarette manufacturers attempt to provide a
consistent product by adding chemical constituents such as flavorings and nicotine to cigarettes and
researchers can elect to use research cigarettes such as 1R6F available from the Center for Tobacco
Reference Products produced by the University of Kentucky. There are no reference biomass fuels
available specifically made for research purposes.
In-vitro biomass smoke exposure models are based on cigarette smoke exposure models, but the
method of biomass smoke exposure varies from study to study. In Vitro, cells can be exposed to
smoke directly, or to constituents of the smoke. In Vivo the airways are covered by a layer of liquid
known as airway surface liquid. This thin layer of liquid regulates airway homeostasis by entrapping
particulate matter, bacteria and other inhaled materials [97]. As such, many researchers reason that
bioactive compounds in biomass smoke need to be soluble in order to pass this liquid layer and to
act upon the underlying cells. Practically this can be achieved by bubbling the smoke through liquid
to make biomass smoke extract (analogous to cigarette smoke extract). Variables in the generation of
biomass smoke extract include the mass of biomass combusted, the temperature of combustion (e.g.,
if a furnace used), the source of the biomass, the rate of smoke passing through the medium, which
medium is used, the amount of medium, the length of tubing from the biomass to the medium, the
size of the vessel used to condition the medium with smoke, and the amount of time (if any) at the end
of combustion which smoke is left in contact with the medium.
In our experiments, we have taken a pragmatic approach. We use the same mass of biomass as
the amount of tobacco found in 1 standard commercial cigarette (so that we can compare to cigarettes).
We ignited the biomass using a gas lighter (to avoid chemicals found in matches), and allowed
the biomass to burn unaided (representing an open fire pit), and drew the smoke at a rate which
allowed combustion to occur over two minutes. The flow rate will control both the amount of oxygen
supplied to the burning biomass and the exposure time if using a bubbling extraction system. We use a
disposable collection system in which a 175 cm2 tissue culture flask which contains 25 mL of medium
(without FBS to avoid bubbling), as residue from the smoke builds upon the flasks. The lack of protein
in the medium, in particular albumin, is worth some discussion. It is known that direct exposure of
albumin to cigarette smoke extract results in carbonlyation (a type of oxidative modification) [98].
It is not known if greater oxidative modifications of proteins would occur if they were contained in
the medium at the time of harvest, or if the oxidatively modified proteins have different bioactivity
compared to none modified proteins. Following 5 min of smoke absorption, the biomass extract
solution is defined as 100% and immediately diluted to working concentrations (typically 1–10% in
medium containing 0.1–10% FBS (depending upon the required growth conditions). This medium
is then applied in vitro for up-to 72 h. One of the underappreciated aspects of in vitro treatment is
that the “smoke” can leach from one well to another. This can result in control cell cultures having
exposure and confounding results. This is by no means the ideal way to treat cells with biomass, but a
methodology, which we have developed over a period of around 5 years.
Earlier mention was made of the issues of working with cells submerged in culture medium.
An alternative is to use systems where epithelial cells are cultured at an air liquid interface and
expose these to gaseous biomass. McCarthy et al. made dung cigarettes, and utilised a commercial
smoking machine (Baumgartner-Jaeger CSM2072i, CH Technologies, Westwood, NJ, USA) to generate
smoke and expose small airway epithelial cells, which had been at air: liquid interface for 24 h [87].
The obvious drawback to this particular system is that cigarettes were made with a filter, as used in a
tobacco cigarette. Exactly which components of dung biomass the filter depleted was not assessed.
Other innovations researchers have used include: (i) using domestic wood stoves to generate
biomass smoke, collecting the PM and adding that to the culture medium [68]; using biomass smoke
derived from fuel burned in a barbecue grill, which is then infused into culture medium [59].
In addition to variations in the choice of fuel and how the smoke is generated, an additional
variant in in vivo animal models of biomass smoke exposure is delivery of the smoke. Exposure can
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either be whole body [99] or nose only [100]. Vlahos and Bozinovski have recently reviewed the
different delivery methods [101]. One aspect of exposure that may not be commonly considered is how
the animals will be housed post-exposure. In whole body exposure regimens, components from the
smoke will coat the fur of the animals, and this is can be later ingested via grooming behaviors [102].
In addition, some animals are coprophagic. Simple measures such as undertaking smoke exposure in
a container that is different to where the animals are housed and also keeping smoke-exposed animals
in separate cages from their unexposed littermates should be used.
11. Concluding Remarks
While smoking rates continue to decline, the burning of biomass for energy is not expected to do
the same and may even increase because of it is a relatively cheap and, particularly in the developed
world, more attractive to electricity and liquid petroleum gas. There is substantial evidence which
links chronic exposure of excess amounts of biomass smoke to adverse health effects notably COPD.
Providing a causative link through in vitro and in vivo studies remains a challenge largely due to
technical problems, which include a lack of standardized sources of biomass smoke as well as no
agreed protocol for its generation and delivery. The issues here can, in some cases, be contrasted as to
what is available with regard to the same sorts of studies investigating cigarette smoke. There is also a
marked paucity of data to understand the nature of exacerbations of biomass induced COPD. Given the
projected rise in the mortality of COPD, the weight of evidence is still not available which would be
the driving impetus for intervention programs that lead to modifications in the use of biomass fuel
and also in controlling people’s exposure.
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